Tafamidis

Cat. No.: PI594839880

Description: Tafamidis free acid form is a non-nonsteroidal anti-inflammatory benzoxazole derivative. Tafamidis, sold under the brand name Vyndamax among others, was developed by FoldRX, now acquired by Pfizer. It was approved by FDA in 2019.

Product Details

CAS	594839-88-0
Trade Names	Vyndamax
Synonyms	2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
Molecular Formula	C14H7Cl2NO3
Molecular Weight	308.114
Available Formulations	Oral Solid
Available DMF/CEP/GMP	US DMF

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *